Related Experiment Videos
Parathyroid carcinoma: an overview
1Department of Pathology, Rhode Island Hospital, Brown Medical School, Providence, Rhode Island 02903, USA. rdelellis@lifespan.org
Advances in Anatomic Pathology
|February 26, 2005
Summary
Parathyroid carcinoma is a rare endocrine malignancy. Genetic mutations in the HRPT2 gene are linked to its development, suggesting a connection to the hyperparathyroidism-jaw tumor syndrome.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Parathyroid carcinoma is a rare cause of hyperparathyroidism (<1%).
- It presents earlier and affects men and women equally, unlike parathyroid adenomas.
- Patients often have severe hypercalcemia and associated bone and kidney issues.
Purpose of the Study:
- To review the characteristics, diagnosis, and management of parathyroid carcinoma.
- To explore the role of the HRPT2 gene and its mutations in parathyroid carcinoma development.
- To highlight the association between parathyroid carcinoma and the hyperparathyroidism-jaw tumor syndrome.
Main Methods:
- Literature review of parathyroid carcinoma cases and HRPT2 gene mutations.
- Analysis of clinical presentation, diagnostic criteria, and treatment outcomes.
- Genetic analysis of tumor and germline DNA.
Main Results:
- Parathyroid carcinoma diagnosis requires evidence of invasion or metastasis; fibrosis and mitotic activity are not specific.
- HRPT2 gene mutations are found in a significant proportion of parathyroid carcinomas.
- Germline HRPT2 mutations are identified in some patients, suggesting a link to hereditary syndromes.
Conclusions:
- Parathyroid carcinoma diagnosis relies on pathological evidence of local invasion or distant metastases.
- HRPT2 gene mutations are crucial in the etiology of many parathyroid carcinomas.
- Some sporadic cases may represent undiagnosed hyperparathyroidism-jaw tumor syndrome or related conditions, necessitating careful genetic evaluation.